Saturn V Capital Management LP 13D/13G Filings for Immix Biopharma, Inc. (IMMX)

Saturn V Capital Management LP 13D and 13G filings for Immix Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
2:50 pm
Purchase
2025-12-2613GIMMIX BIOPHARMA INC
IMMX
Saturn V Capital Management LP3,693,585
6.970%
3,693,585increase
(New Position)
Filing